Can Repatha and Migraine drug mitigate the sales of Neulasta, Epogen and Senipar generics?

[anonymous]

All those products will have competition entering this year or early 2019.

Migraine will have competition soon too so how feasible will it be to grow without significant price increases?

 

[anonymous]

LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!! LAYOFFS LAYOFFS LAYOFFS!!!!!!!!!!!